Papers
2
Total Citations
44
H-Index
2
About
Ai-Qing Ma is a pioneer in the emerging field of biohybrid micro-/nanorobotics for precision medicine, with a core focus on gastritis therapy and cancer immune modulation. Their most impactful work introduces a groundbreaking "self-driving yeast micro-/nanorobot" (Cur@CaY-robot), which leverages dual biomineralization and acid catalysis to achieve autonomous penetration and drug delivery for treating gastritis and restoring gastrointestinal motility. This innovative approach, detailed in their 2023 highly-cited paper (42 citations), addresses the critical challenge of biocompatibility in robotic therapeutics. Ma also contributes significantly to the design of cell- and bacteria-based bioactive materials for personalized cancer therapy, as featured in a 2021 *Advanced Materials* article. Their research uniquely bridges synthetic biology and materials science, demonstrating how living organisms can be engineered into therapeutic robots. With a growing citation impact, Ma’s work is at the forefront of developing intelligent, self-propelling systems that promise to revolutionize targeted drug delivery and regenerative medicine.
Research Focus
Key Achievements
Top Papers
- 1
- 2